Clinical Trial Update: Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of anastrozole and a GnRH agonist for recurrent endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Anastrozole (Anastrozole)
• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Endometriosis | Phase 4 | Status: COMPLETED